Literature DB >> 8166774

Aminoglycoside volume of distribution in postoperative patients with septic shock.

E C Oparaoji1, E E Cornwell, E Hekmat, R Lum Cheong, J S Adir, S Siram.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8166774

Source DB:  PubMed          Journal:  Clin Pharm        ISSN： 0278-2677


× No keyword cloud information.
  8 in total

1.  The effect of sepsis upon gentamicin pharmacokinetics in neonates.

Authors:  M Lingvall; D Reith; R Broadbent
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

Review 2.  Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Authors:  Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies.

Authors:  Amélie Marsot; Romain Guilhaumou; Camille Riff; Olivier Blin
Journal:  Clin Pharmacokinet       Date:  2017-02       Impact factor: 6.447

4.  Population pharmacokinetics of Arbekacin in patients infected with methicillin-resistant Staphylococcus aureus.

Authors:  Yusuke Tanigawara; Reiko Sato; Kunihiko Morita; Mitsuo Kaku; Naoki Aikawa; Kihachiro Shimizu
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

5.  Relationship between pharmacokinetic parameters of gentamicin and patient characteristics and/or clinical data in patients with solid organ tumours.

Authors:  A Ortega; A Aldaz; J Giráldez; A Brugarolas
Journal:  Pharm World Sci       Date:  1999-10

6.  Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock.

Authors:  Fabio Silvio Taccone; Pierre-François Laterre; Herbert Spapen; Thierry Dugernier; Isabelle Delattre; Brice Layeux; Daniel De Backer; Xavier Wittebole; Pierre Wallemacq; Jean-Louis Vincent; Frédérique Jacobs
Journal:  Crit Care       Date:  2010-04-06       Impact factor: 9.097

7.  Influence of clinical diagnosis in the population pharmacokinetics of amikacin in intensive care unit patients.

Authors:  S Romano; M Del Mar Fdez de Gatta; V Calvo; E Mendez; A Domínguez-Gil; J M Lanao
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

8.  Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis.

Authors:  Sabrina De Winter; Reinier van Hest; Erwin Dreesen; Pieter Annaert; Joost Wauters; Wouter Meersseman; Nele Van den Eede; Stefanie Desmet; Sandra Verelst; Peter Vanbrabant; Willy Peetermans; Isabel Spriet
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-07-23       Impact factor: 2.441
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.